Development and evaluation of mucoadhesive nanoparticles based on thiolated Eudragit for oral delivery of protein drugs

详细信息    查看全文

• 作者：Yan Zhang ; Zhijie Yang ; Xi Hu ; Ling Zhang ; Feng Li…
• 关键词：Eudragit L100 ; cysteine ; Nanoparticles ; pH sensitive ; Mucoadhesive ; Enzymatic inhibition ; Nanomedicine
• 刊名：Journal of Nanoparticle Research
• 出版年：2015
• 出版时间：February 2015
• 年：2015
• 卷：17
• 期：2
• 全文大小：965 KB
• 参考文献：1. Andreani T, Luiza A, Souto EB et al (2014) Preparation and characterization of PEG-coated silica nanoparticles for oral insulin delivery. Int J Pharm 473:627-35 CrossRef
  2. Bakhru SH, Furtado S, Mathiowitz E et al (2013) Oral delivery of proteins by biodegradable nanoparticles. Adv Drug Deliv Rev 65:811-21 CrossRef
  3. Bernkop-Schnürch A (2005) Mucoadhesive polymers: strategies, achievements and future challenges. Adv Drug Deliv Rev 57:1553-555 CrossRef
  4. Bernkop-Schnürch A, Freudl A (1999) Comparative in vitro study of different chitosan-complexing agent conjugates. Pharmazie 54:369-71
  5. Bernkop-Schnürch A, Krajicek ME (1998) Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates. J Controlled Release 50:215-23 CrossRef
  6. Bernkop-Schnürch A, Zarti H, Walker GF (2001) Thiolation of polycarbophil enhances its inhibition of intestinal brush border membrane bound aminopeptidase N. J Pharm Sci 90:1907-914 CrossRef
  7. Bravo-Osuna I, Millotti G, Vauthier C et al (2007) In vitro evaluation of calcium-binding capacity of chitosan and thiolated chitosan poly(isobutyl cyanoacrylate) core-shell nanoparticles. Int J Pharm 338:284-90 CrossRef
  8. Chickering DE, Mathiowitz E (1995) Bioadhesive microspheres: I. A novel electrobalance-based method to study adhesive interactions between individual microspheres and intestinal mucosa. J Controlled Release 34:251-62 CrossRef
  9. Felber AE, Dufresne MH, Leroux JC (2012) pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates. Adv Drug Deliv Rev 64:979-92 CrossRef
  10. Ganta S, Devalapally H, Amiji M et al (2008) A review of stimuli-responsive nanocarriers for drug and gene delivery. J Controlled Release 126:187-04 CrossRef
  11. Herrero-Vanrell R, Rincón AC, Rodríguez-Cabello JC et al (2005) Self-assembled particles of an elastin-like polymer as vehicles for controlled drug release. J Controlled Release 102:113-22 CrossRef
  12. Jin Y, Song Y, Huang Y et al (2012) Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport. Biomaterials 33:1573-582 CrossRef
  13. Kim BG, Kang IJ (2008) Evaluation of the effects of biodegradable nanoparticles on a vaccine delivery system using AFM, SEM and TEM. Ultramicroscopy 108:1168-173 CrossRef
  14. Luessen HL, Verhoef JC, Junginger HE et al (1995) Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin. Pharm Res 12:1293-298 CrossRef
  15. Luessen HL, de Leeuw BJ, Junginger HE et al (1996) Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm Res 13:1668-672 CrossRef
  16. Mao S, Bakowsky U, Kissel T et al (2006) Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin. J Pharm Sci 95:1035-048 CrossRef
  17. Mukhopadhyay P, Sarkar K, Kundu PP et
• 刊物类别：Chemistry and Materials Science
• 刊物主题：Chemistry
  Nanotechnology
  Inorganic Chemistry
  Characterization and Evaluation Materials
  Physical Chemistry
  Applied Optics, Optoelectronics and Optical Devices
  
• 出版者：Springer Netherlands
• ISSN：1572-896X

文摘

The objective of this study was to develop pH-sensitive Eudragit L100–cysteine/reduced glutathione (Eul–cys/GSH) nanoparticles (NPs), which provided the mucoadhesion and protection for protein drugs against enzymatic degradation. Insulin was chosen as a model biomolecule for testing this system. The Eul–cys conjugate, which was obtained by grafting cysteine onto the carboxy group of Eudragit L100, was analyzed by HNMR and SEM, and the swelling degree (SD), cation binding, and enzymatic inhibition were also determined. The results obtained showed that the Eul–cys conjugate represent a pH-sensitive delivery system which effectively protected the insulin from being degraded by the proteases, and this is related to the mechanism of Ca2+ binding. Insulin-loaded Eul–cys/GSH NPs were prepared by a diffusion method involving an electrostatic interaction between the network structure of the polymer and the embedded proteins, including insulin and GSH. TEM images indicated that Eul–cys/GSH existed as smooth and spherical NPs in aqueous solution with particle sizes of 260?±?20?nm. The X-ray diffraction (XRD) and X-ray photoelectron spectroscopy (XPS) findings showed the presence of amorphous insulin in thiolated NPs and higher free thiol oxidation than the result obtained by Ellman’s reagent method. In addition, thiolated NPs showed excellent binding efficiency to the mucin in rat intestine, indicating that Eul–cys/GSH NPs have great potential to be applied as safe carriers for the oral administration of protein drugs.